A novel missense mutation C127R (FH Zagreb) in the LDL-receptor gene

A S Rukavina1, R Z Topić, G Ferencak

  • 1Clinical Institute of Laboratory Diagnosis, Zagreb University School of Medicine and Clinical Hospital Center, Croatia. ana.stavljenic-rukavina@zg.tel.hr

Insights

Researchers identified two mutations, C127R and D200G, in the low-density lipoprotein receptor gene linked to familial hypercholesterolemia. The novel C127R mutation was found in Croatian patients, contributing to genetic understanding of the disease.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiovascular Disease

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein (LDL) cholesterol.
  • Mutations in the LDL receptor (LDLR) gene are a primary cause of FH.
  • Identifying specific mutations is crucial for genetic diagnosis and understanding disease prevalence.

Purpose of the Study:

  • To identify novel mutations in the LDLR gene responsible for familial hypercholesterolemia.
  • To characterize the prevalence of specific LDLR mutations in a Croatian FH population.

Main Methods:

  • Single-strand conformation polymorphism (SSCP) analysis was used to screen for mutations in exon 4 of the LDLR gene.
  • DNA sequencing was employed to confirm and characterize identified mutations.
  • Restriction endonuclease analysis (Dsa I) was used to validate the novel C127R mutation.

Main Results:

  • Two mutations, C127R (FH Zagreb) and D200G (FH Padova), were identified in exon 4 of the LDLR gene.
  • The C127R mutation, a novel T-to-C substitution at nucleotide 442, results in an amino acid change from Cysteine to Arginine at codon 127.
  • The D200G mutation, an A-to-G substitution at nucleotide 662, changes Aspartic acid to Glycine at codon 200.
  • These two mutations account for approximately 0.7% of FH cases in the screened Croatian population.

Conclusions:

  • A novel mutation, C127R, in the LDLR gene causing familial hypercholesterolemia has been identified and characterized.
  • The identified mutations, C127R and D200G, contribute to the genetic landscape of familial hypercholesterolemia in Croatia.
  • This study highlights the importance of mutation screening for understanding FH etiology and epidemiology.

Related Concept Videos

Mutations01:39

Mutations

Overview
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...